Dreavent Capital
Investments
2
Lead Investments
2
Dreavent Capital is a strategic investment firm focused on funding biotech therapeutics companies. They invest in early-stage biotechnology and healthcare companies, with a focus on therapeutics in areas such as Oncology, Neurology, Cardiovascular & Metabolic, and Immunology. Their investment strategy spans Europe and North America, and they are strategically located in a prominent biotech hub.
Highlights
Focus Areas
Biotechnology
Clinical Trials
Life Science
Pharmaceutical
Therapeutics
Investment Types
Early Stage Venture
Notable Investments
